Rank | Gene Set | Z-score |
---|---|---|
1 | neuron cell-cell adhesion (GO:0007158) | 5.73319114 |
2 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.39264179 |
3 | endocrine pancreas development (GO:0031018) | 4.90186767 |
4 | epithelial cell fate commitment (GO:0072148) | 4.54935575 |
5 | inositol phosphate catabolic process (GO:0071545) | 4.49813712 |
6 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.43103063 |
7 | inositol phosphate dephosphorylation (GO:0046855) | 4.43103063 |
8 | insulin secretion (GO:0030073) | 4.31373271 |
9 | signal peptide processing (GO:0006465) | 4.18275714 |
10 | melanin biosynthetic process (GO:0042438) | 4.16102535 |
11 | peptide hormone processing (GO:0016486) | 4.14989460 |
12 | ketone body metabolic process (GO:1902224) | 4.09059531 |
13 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.98051032 |
14 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.95973928 |
15 | cellular ketone body metabolic process (GO:0046950) | 3.86351723 |
16 | positive regulation of glycolytic process (GO:0045821) | 3.83112141 |
17 | gonadal mesoderm development (GO:0007506) | 3.80244463 |
18 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.78322194 |
19 | positive regulation of insulin secretion (GO:0032024) | 3.75150538 |
20 | vocalization behavior (GO:0071625) | 3.72350421 |
21 | lactate metabolic process (GO:0006089) | 3.71633243 |
22 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.71508182 |
23 | phagosome maturation (GO:0090382) | 3.71236762 |
24 | melanin metabolic process (GO:0006582) | 3.66290991 |
25 | regulation of penile erection (GO:0060405) | 3.65077623 |
26 | startle response (GO:0001964) | 3.58611229 |
27 | nitric oxide mediated signal transduction (GO:0007263) | 3.57255039 |
28 | positive regulation of macroautophagy (GO:0016239) | 3.53411145 |
29 | presynaptic membrane assembly (GO:0097105) | 3.51109264 |
30 | polyol catabolic process (GO:0046174) | 3.47958394 |
31 | positive regulation of gluconeogenesis (GO:0045722) | 3.45575986 |
32 | positive regulation of response to nutrient levels (GO:0032109) | 3.43830523 |
33 | positive regulation of response to extracellular stimulus (GO:0032106) | 3.43830523 |
34 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.42948123 |
35 | negative regulation of neurological system process (GO:0031645) | 3.41343552 |
36 | macroautophagy (GO:0016236) | 3.41183884 |
37 | transferrin transport (GO:0033572) | 3.40656201 |
38 | glandular epithelial cell differentiation (GO:0002067) | 3.34495772 |
39 | secondary metabolite biosynthetic process (GO:0044550) | 3.34276395 |
40 | regulation of autophagic vacuole assembly (GO:2000785) | 3.33122824 |
41 | positive regulation of peptide hormone secretion (GO:0090277) | 3.31632074 |
42 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.30827829 |
43 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.27501537 |
44 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.27501537 |
45 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.25689677 |
46 | trivalent inorganic cation transport (GO:0072512) | 3.21886715 |
47 | ferric iron transport (GO:0015682) | 3.21886715 |
48 | protein localization to synapse (GO:0035418) | 3.19625006 |
49 | xenobiotic catabolic process (GO:0042178) | 3.17042525 |
50 | endosome to pigment granule transport (GO:0043485) | 3.15660641 |
51 | endosome to melanosome transport (GO:0035646) | 3.15660641 |
52 | positive regulation of peptide secretion (GO:0002793) | 3.15489468 |
53 | synaptic vesicle exocytosis (GO:0016079) | 3.13692578 |
54 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.12636268 |
55 | oligosaccharide catabolic process (GO:0009313) | 3.11435729 |
56 | presynaptic membrane organization (GO:0097090) | 3.10231366 |
57 | postsynaptic membrane organization (GO:0001941) | 3.09925170 |
58 | type B pancreatic cell development (GO:0003323) | 3.09455215 |
59 | negative regulation of protein oligomerization (GO:0032460) | 3.07328512 |
60 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.06836435 |
61 | detection of calcium ion (GO:0005513) | 3.06809896 |
62 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.05906706 |
63 | nitric oxide biosynthetic process (GO:0006809) | 3.05810082 |
64 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.04369528 |
65 | regulation of glucokinase activity (GO:0033131) | 3.03892768 |
66 | regulation of hexokinase activity (GO:1903299) | 3.03892768 |
67 | glucosamine-containing compound catabolic process (GO:1901072) | 3.01538181 |
68 | regulation of vacuole organization (GO:0044088) | 3.00186048 |
69 | retinal rod cell development (GO:0046548) | 2.99439990 |
70 | pigment cell differentiation (GO:0050931) | 2.99362551 |
71 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.99195031 |
72 | sphingomyelin metabolic process (GO:0006684) | 2.94843063 |
73 | mating behavior (GO:0007617) | 2.94287529 |
74 | peptide hormone secretion (GO:0030072) | 2.93725429 |
75 | sequestering of metal ion (GO:0051238) | 2.92657472 |
76 | regulation of insulin secretion (GO:0050796) | 2.91477426 |
77 | developmental pigmentation (GO:0048066) | 2.90717645 |
78 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.87830382 |
79 | regulation of transmission of nerve impulse (GO:0051969) | 2.87190529 |
80 | negative regulation of acute inflammatory response (GO:0002674) | 2.86791313 |
81 | positive regulation of calcium ion import (GO:0090280) | 2.85443338 |
82 | peptide secretion (GO:0002790) | 2.84961629 |
83 | negative regulation of complement activation (GO:0045916) | 2.83566193 |
84 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.79824605 |
85 | neuromuscular process controlling posture (GO:0050884) | 2.79780527 |
86 | cerebellar granule cell differentiation (GO:0021707) | 2.79326546 |
87 | response to histamine (GO:0034776) | 2.78060544 |
88 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.78037914 |
89 | auditory receptor cell differentiation (GO:0042491) | 2.77191002 |
90 | regulation of B cell apoptotic process (GO:0002902) | 2.76920734 |
91 | long-term synaptic potentiation (GO:0060291) | 2.76735808 |
92 | regulation of extracellular matrix disassembly (GO:0010715) | 2.74432760 |
93 | positive regulation of synapse assembly (GO:0051965) | 2.74404130 |
94 | regulation of fever generation (GO:0031620) | 2.73510798 |
95 | regulation of axon regeneration (GO:0048679) | 2.72678157 |
96 | regulation of neuron projection regeneration (GO:0070570) | 2.72678157 |
97 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.71817940 |
98 | negative regulation of mast cell activation (GO:0033004) | 2.70759014 |
99 | phospholipid dephosphorylation (GO:0046839) | 2.70297157 |
100 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.70172237 |
101 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.70115842 |
102 | detection of light stimulus involved in visual perception (GO:0050908) | 2.70110728 |
103 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.70110728 |
104 | microglial cell activation (GO:0001774) | 2.67771519 |
105 | positive regulation of heat generation (GO:0031652) | 2.66351890 |
106 | regulation of energy homeostasis (GO:2000505) | 2.65470350 |
107 | regulation of beta-amyloid formation (GO:1902003) | 2.64844310 |
108 | regulation of peptide hormone secretion (GO:0090276) | 2.64098952 |
109 | positive regulation of protein autophosphorylation (GO:0031954) | 2.63924686 |
110 | respiratory chain complex IV assembly (GO:0008535) | 2.63138800 |
111 | astrocyte differentiation (GO:0048708) | 2.61990241 |
112 | glandular epithelial cell development (GO:0002068) | 2.60498688 |
113 | fatty acid homeostasis (GO:0055089) | 2.59033951 |
114 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.58893513 |
115 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.58092526 |
116 | positive regulation by symbiont of host defense response (GO:0052509) | 2.57627964 |
117 | modulation by symbiont of host defense response (GO:0052031) | 2.57627964 |
118 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.57627964 |
119 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.57627964 |
120 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.57627964 |
121 | modulation by symbiont of host immune response (GO:0052553) | 2.57627964 |
122 | regulation of peptide secretion (GO:0002791) | 2.57007848 |
123 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.56069243 |
124 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.55272275 |
125 | neurotransmitter secretion (GO:0007269) | 2.55224503 |
126 | regulation of glutamate secretion (GO:0014048) | 2.55133602 |
127 | negative regulation of gluconeogenesis (GO:0045721) | 2.53083647 |
128 | cytochrome complex assembly (GO:0017004) | 2.52140830 |
129 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.51907134 |
130 | fatty acid elongation (GO:0030497) | 2.51558193 |
131 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.51171347 |
132 | melanocyte differentiation (GO:0030318) | 2.51021456 |
133 | peptide transport (GO:0015833) | 2.50433702 |
134 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.49788243 |
135 | positive regulation of autophagy (GO:0010508) | 2.49710991 |
136 | macrophage activation (GO:0042116) | 2.48878474 |
137 | locomotory exploration behavior (GO:0035641) | 2.48183545 |
138 | righting reflex (GO:0060013) | 2.47185977 |
139 | negative regulation of amino acid transport (GO:0051956) | 2.47144431 |
140 | regulation of memory T cell differentiation (GO:0043380) | 2.47008475 |
141 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.46614790 |
142 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.46595535 |
143 | nodal signaling pathway (GO:0038092) | 2.46528124 |
144 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.45671818 |
145 | response to glucose (GO:0009749) | 2.45301251 |
146 | proline transport (GO:0015824) | 2.45206212 |
147 | positive regulation of hormone secretion (GO:0046887) | 2.45177902 |
148 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.44946401 |
149 | zinc ion homeostasis (GO:0055069) | 2.44568619 |
150 | negative regulation of neurotransmitter transport (GO:0051589) | 2.43706933 |
151 | iron ion transport (GO:0006826) | 2.42244175 |
152 | regulation of feeding behavior (GO:0060259) | 2.41050846 |
153 | intracellular pH reduction (GO:0051452) | 2.40867877 |
154 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.40862514 |
155 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.39788778 |
156 | pH reduction (GO:0045851) | 2.39017888 |
157 | regulation of heat generation (GO:0031650) | 2.36803859 |
158 | eosinophil chemotaxis (GO:0048245) | 2.35393648 |
159 | gamma-aminobutyric acid transport (GO:0015812) | 2.34696595 |
160 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.33459871 |
161 | synapse assembly (GO:0007416) | 2.32249257 |
162 | neutrophil activation involved in immune response (GO:0002283) | 2.31905520 |
163 | innervation (GO:0060384) | 2.30601995 |
164 | neurotransmitter biosynthetic process (GO:0042136) | 2.30517332 |
165 | neurotransmitter transport (GO:0006836) | 2.29717331 |
166 | detection of molecule of bacterial origin (GO:0032490) | 2.29016791 |
167 | membrane hyperpolarization (GO:0060081) | 2.28193015 |
168 | aldehyde catabolic process (GO:0046185) | 2.28146430 |
169 | opsonization (GO:0008228) | 2.26848447 |
170 | striatum development (GO:0021756) | 2.25881546 |
171 | regulation of synaptic vesicle transport (GO:1902803) | 2.25223776 |
172 | neuron recognition (GO:0008038) | 2.24917843 |
173 | neuron-neuron synaptic transmission (GO:0007270) | 2.23840181 |
174 | positive regulation of macrophage cytokine production (GO:0060907) | 2.21623519 |
175 | glycosphingolipid catabolic process (GO:0046479) | 2.21540723 |
176 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.20224319 |
177 | exploration behavior (GO:0035640) | 2.19969418 |
178 | glycerophospholipid catabolic process (GO:0046475) | 2.19316265 |
179 | dopamine biosynthetic process (GO:0042416) | 2.18219631 |
180 | adult walking behavior (GO:0007628) | 2.17638919 |
181 | cellular potassium ion homeostasis (GO:0030007) | 2.17346650 |
182 | response to auditory stimulus (GO:0010996) | 2.16710364 |
183 | membrane assembly (GO:0071709) | 2.14790515 |
184 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.14230094 |
185 | negative regulation of amine transport (GO:0051953) | 2.13182336 |
186 | regulation of cellular amide metabolic process (GO:0034248) | 2.13173226 |
187 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.12380599 |
188 | cofactor catabolic process (GO:0051187) | 2.12020480 |
189 | regulation of dopamine metabolic process (GO:0042053) | 2.11405584 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.94266132 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.87107902 |
3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.98525533 |
4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.84561350 |
5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.61527829 |
6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.41821071 |
7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.40992550 |
8 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.38886914 |
9 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.37435318 |
10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32855505 |
11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.15894580 |
12 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.12947028 |
13 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.12601061 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.08465589 |
15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.04046749 |
16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.00822705 |
17 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.97400382 |
18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.92215270 |
19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91221419 |
20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.89111077 |
21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.87653906 |
22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.86986683 |
23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.86097590 |
24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.81596763 |
25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.80111022 |
26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.75052846 |
27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74997638 |
28 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.74132001 |
29 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.73946154 |
30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.72501479 |
31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.72166312 |
32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71396223 |
33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.70772452 |
34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.70099285 |
35 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.69815573 |
36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.69657090 |
37 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.69657090 |
38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67236918 |
39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65362422 |
40 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61017664 |
41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.57097952 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56596537 |
43 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.54854783 |
44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.52222359 |
45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.52221851 |
46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51439920 |
47 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.51431381 |
48 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.51431381 |
49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47861830 |
50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.47332151 |
51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42129783 |
52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.42019303 |
53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39833964 |
54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38696444 |
55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38426330 |
56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37808305 |
57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.37396963 |
58 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.36556143 |
59 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.36479236 |
60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36372766 |
61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36000352 |
62 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33704654 |
63 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.33170319 |
64 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32529892 |
65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32491364 |
66 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.32042274 |
67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30301009 |
68 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28841823 |
69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28192311 |
70 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26758386 |
71 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.24941737 |
72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24425331 |
73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23696438 |
74 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23266204 |
75 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22684165 |
76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20318760 |
77 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.20229886 |
78 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19988900 |
79 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19909921 |
80 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19909921 |
81 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19113445 |
82 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19103256 |
83 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18904454 |
84 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16722063 |
85 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16693923 |
86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15997900 |
87 | * JUN_21703547_ChIP-Seq_K562_Human | 1.14666989 |
88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14478610 |
89 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14015192 |
90 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.13969608 |
91 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13953654 |
92 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13225315 |
93 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12815257 |
94 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12364515 |
95 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.12298624 |
96 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.11304323 |
97 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11100000 |
98 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.09823361 |
99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09639465 |
100 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08936207 |
101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08564045 |
102 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08295923 |
103 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.06927307 |
104 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.06838058 |
105 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06672079 |
106 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06268072 |
107 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.06066153 |
108 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05767686 |
109 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05535629 |
110 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05139913 |
111 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04172923 |
112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04116865 |
113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04028468 |
114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03845715 |
115 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03389456 |
116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03193208 |
117 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02748376 |
118 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02748376 |
119 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02611531 |
120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02245119 |
121 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.01661872 |
122 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01350627 |
123 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01278998 |
124 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00960495 |
125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00470352 |
126 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00011952 |
127 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99775663 |
128 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98284621 |
129 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98243846 |
130 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98081381 |
131 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98081381 |
132 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97994821 |
133 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97922578 |
134 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97741454 |
135 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97616578 |
136 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97450067 |
137 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.96384784 |
138 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96222072 |
139 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96192870 |
140 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96056258 |
141 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.96041420 |
142 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95926790 |
143 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.94981187 |
144 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94418266 |
145 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94311374 |
146 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93975499 |
147 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93880277 |
148 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93257688 |
149 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93154659 |
150 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92715371 |
151 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.92056708 |
152 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91945218 |
153 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91481522 |
154 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90413679 |
155 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.90331789 |
156 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90218768 |
157 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.89742401 |
158 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88952349 |
159 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.88692455 |
160 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88411890 |
161 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87044413 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 4.28690110 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 3.97091578 |
3 | MP0005379_endocrine/exocrine_gland_phen | 3.61289349 |
4 | MP0003880_abnormal_central_pattern | 3.55431902 |
5 | MP0002822_catalepsy | 3.37352773 |
6 | MP0000372_irregular_coat_pigmentation | 3.35263322 |
7 | MP0005075_abnormal_melanosome_morpholog | 3.25408060 |
8 | MP0002163_abnormal_gland_morphology | 2.99732760 |
9 | MP0003195_calcinosis | 2.80834200 |
10 | MP0002693_abnormal_pancreas_physiology | 2.80384681 |
11 | MP0000015_abnormal_ear_pigmentation | 2.79209699 |
12 | MP0003787_abnormal_imprinting | 2.58190039 |
13 | MP0001944_abnormal_pancreas_morphology | 2.51807763 |
14 | MP0002064_seizures | 2.44938514 |
15 | MP0009046_muscle_twitch | 2.34233308 |
16 | MP0005408_hypopigmentation | 2.31462513 |
17 | MP0005551_abnormal_eye_electrophysiolog | 2.29088995 |
18 | MP0005058_abnormal_lysosome_morphology | 2.26522068 |
19 | MP0000604_amyloidosis | 2.21432997 |
20 | MP0005423_abnormal_somatic_nervous | 2.18086468 |
21 | MP0003950_abnormal_plasma_membrane | 2.17342058 |
22 | MP0010386_abnormal_urinary_bladder | 2.12810119 |
23 | MP0002090_abnormal_vision | 2.11776710 |
24 | MP0006082_CNS_inflammation | 2.11553729 |
25 | MP0003635_abnormal_synaptic_transmissio | 2.10961836 |
26 | MP0005174_abnormal_tail_pigmentation | 2.08557585 |
27 | MP0009745_abnormal_behavioral_response | 2.07040868 |
28 | MP0000013_abnormal_adipose_tissue | 2.06716373 |
29 | MP0003283_abnormal_digestive_organ | 2.04805441 |
30 | MP0000920_abnormal_myelination | 2.03333238 |
31 | MP0003172_abnormal_lysosome_physiology | 2.02604142 |
32 | MP0001529_abnormal_vocalization | 2.02453231 |
33 | MP0003011_delayed_dark_adaptation | 1.99473056 |
34 | MP0005171_absent_coat_pigmentation | 1.98678986 |
35 | MP0003690_abnormal_glial_cell | 1.93622959 |
36 | MP0001968_abnormal_touch/_nociception | 1.93454956 |
37 | MP0001984_abnormal_olfaction | 1.93222950 |
38 | MP0004381_abnormal_hair_follicle | 1.87957028 |
39 | MP0002572_abnormal_emotion/affect_behav | 1.85497755 |
40 | MP0006276_abnormal_autonomic_nervous | 1.85114805 |
41 | MP0003183_abnormal_peptide_metabolism | 1.84810385 |
42 | MP0000569_abnormal_digit_pigmentation | 1.80880537 |
43 | MP0001440_abnormal_grooming_behavior | 1.79452020 |
44 | MP0002272_abnormal_nervous_system | 1.79068367 |
45 | MP0002063_abnormal_learning/memory/cond | 1.78877271 |
46 | MP0003329_amyloid_beta_deposits | 1.77367600 |
47 | MP0004142_abnormal_muscle_tone | 1.74247413 |
48 | MP0003122_maternal_imprinting | 1.73941906 |
49 | MP0002736_abnormal_nociception_after | 1.72524381 |
50 | MP0001486_abnormal_startle_reflex | 1.68650821 |
51 | MP0005220_abnormal_exocrine_pancreas | 1.65244433 |
52 | MP0002078_abnormal_glucose_homeostasis | 1.64521680 |
53 | MP0001905_abnormal_dopamine_level | 1.63709709 |
54 | MP0000371_diluted_coat_color | 1.60129542 |
55 | MP0003879_abnormal_hair_cell | 1.59973624 |
56 | MP0008438_abnormal_cutaneous_collagen | 1.59463557 |
57 | MP0002277_abnormal_respiratory_mucosa | 1.57593077 |
58 | MP0002254_reproductive_system_inflammat | 1.55169940 |
59 | MP0003634_abnormal_glial_cell | 1.52448307 |
60 | MP0003724_increased_susceptibility_to | 1.51940647 |
61 | MP0004742_abnormal_vestibular_system | 1.51605531 |
62 | MP0001501_abnormal_sleep_pattern | 1.49696403 |
63 | MP0005645_abnormal_hypothalamus_physiol | 1.47698601 |
64 | MP0010329_abnormal_lipoprotein_level | 1.47418552 |
65 | MP0002067_abnormal_sensory_capabilities | 1.46697745 |
66 | MP0004859_abnormal_synaptic_plasticity | 1.46368800 |
67 | MP0008877_abnormal_DNA_methylation | 1.45646491 |
68 | MP0002735_abnormal_chemical_nociception | 1.45573212 |
69 | MP0002734_abnormal_mechanical_nocicepti | 1.44150553 |
70 | MP0005164_abnormal_response_to | 1.43464245 |
71 | MP0001958_emphysema | 1.43049593 |
72 | MP0005253_abnormal_eye_physiology | 1.40501324 |
73 | MP0002095_abnormal_skin_pigmentation | 1.40483573 |
74 | MP0001756_abnormal_urination | 1.40151899 |
75 | MP0005646_abnormal_pituitary_gland | 1.36519359 |
76 | MP0009785_altered_susceptibility_to | 1.31041356 |
77 | MP0001502_abnormal_circadian_rhythm | 1.30977820 |
78 | MP0005248_abnormal_Harderian_gland | 1.26290633 |
79 | MP0004019_abnormal_vitamin_homeostasis | 1.25042923 |
80 | MP0000639_abnormal_adrenal_gland | 1.23273399 |
81 | MP0002928_abnormal_bile_duct | 1.22896323 |
82 | MP0004883_abnormal_blood_vessel | 1.20911092 |
83 | MP0001970_abnormal_pain_threshold | 1.19808317 |
84 | MP0005386_behavior/neurological_phenoty | 1.17166756 |
85 | MP0004924_abnormal_behavior | 1.17166756 |
86 | MP0002733_abnormal_thermal_nociception | 1.15694717 |
87 | MP0004858_abnormal_nervous_system | 1.14955698 |
88 | MP0002229_neurodegeneration | 1.13100670 |
89 | MP0003136_yellow_coat_color | 1.11757248 |
90 | MP0005084_abnormal_gallbladder_morpholo | 1.10208254 |
91 | MP0003123_paternal_imprinting | 1.07724801 |
92 | MP0002876_abnormal_thyroid_physiology | 1.06285984 |
93 | MP0005636_abnormal_mineral_homeostasis | 1.06221040 |
94 | MP0002148_abnormal_hypersensitivity_rea | 1.04281879 |
95 | MP0003632_abnormal_nervous_system | 1.04246024 |
96 | MP0003303_peritoneal_inflammation | 1.02609624 |
97 | MP0002638_abnormal_pupillary_reflex | 1.01495819 |
98 | MP0001765_abnormal_ion_homeostasis | 1.01438202 |
99 | MP0008260_abnormal_autophagy | 1.01379623 |
100 | MP0008875_abnormal_xenobiotic_pharmacok | 1.00915764 |
101 | MP0002139_abnormal_hepatobiliary_system | 1.00679532 |
102 | MP0005332_abnormal_amino_acid | 1.00094745 |
103 | MP0005448_abnormal_energy_balance | 0.99602559 |
104 | MP0003953_abnormal_hormone_level | 0.97395268 |
105 | MP0002419_abnormal_innate_immunity | 0.96563901 |
106 | MP0003075_altered_response_to | 0.96298072 |
107 | MP0002332_abnormal_exercise_endurance | 0.95697182 |
108 | MP0002118_abnormal_lipid_homeostasis | 0.94917721 |
109 | MP0001324_abnormal_eye_pigmentation | 0.94898906 |
110 | MP0006054_spinal_hemorrhage | 0.93799410 |
111 | MP0002184_abnormal_innervation | 0.93761810 |
112 | MP0000343_altered_response_to | 0.92350347 |
113 | MP0002075_abnormal_coat/hair_pigmentati | 0.92245893 |
114 | MP0001186_pigmentation_phenotype | 0.91444220 |
115 | MP0000003_abnormal_adipose_tissue | 0.90088964 |
116 | MP0001661_extended_life_span | 0.89205427 |
117 | MP0004270_analgesia | 0.89147712 |
118 | MP0002882_abnormal_neuron_morphology | 0.88843444 |
119 | MP0004043_abnormal_pH_regulation | 0.87875139 |
120 | MP0002166_altered_tumor_susceptibility | 0.87836317 |
121 | MP0005195_abnormal_posterior_eye | 0.87728857 |
122 | MP0002066_abnormal_motor_capabilities/c | 0.87097369 |
123 | MP0001542_abnormal_bone_strength | 0.86543081 |
124 | MP0003191_abnormal_cellular_cholesterol | 0.86100260 |
125 | MP0002938_white_spotting | 0.86083198 |
126 | MP0009764_decreased_sensitivity_to | 0.84934980 |
127 | MP0002557_abnormal_social/conspecific_i | 0.84715594 |
128 | MP0005365_abnormal_bile_salt | 0.84037886 |
129 | MP0000751_myopathy | 0.83683419 |
130 | MP0006072_abnormal_retinal_apoptosis | 0.81542615 |
131 | MP0002909_abnormal_adrenal_gland | 0.81412360 |
132 | MP0003045_fibrosis | 0.81268019 |
133 | MP0000685_abnormal_immune_system | 0.80552367 |
134 | MP0005595_abnormal_vascular_smooth | 0.80307748 |
135 | MP0005410_abnormal_fertilization | 0.79874212 |
136 | MP0003631_nervous_system_phenotype | 0.79790935 |
137 | MP0000427_abnormal_hair_cycle | 0.78931200 |
138 | MP0004885_abnormal_endolymph | 0.78779152 |
139 | MP0010678_abnormal_skin_adnexa | 0.78739725 |
140 | MP0003300_gastrointestinal_ulcer | 0.77218901 |
141 | MP0001963_abnormal_hearing_physiology | 0.75368769 |
142 | MP0009840_abnormal_foam_cell | 0.74899797 |
143 | MP0005367_renal/urinary_system_phenotyp | 0.74823828 |
144 | MP0000516_abnormal_urinary_system | 0.74823828 |
145 | MP0002168_other_aberrant_phenotype | 0.73938407 |
146 | MP0009697_abnormal_copulation | 0.73754900 |
147 | MP0003121_genomic_imprinting | 0.73114852 |
148 | MP0003633_abnormal_nervous_system | 0.73025704 |
149 | MP0009780_abnormal_chondrocyte_physiolo | 0.72755373 |
150 | MP0005310_abnormal_salivary_gland | 0.71877403 |
151 | MP0006036_abnormal_mitochondrial_physio | 0.69324831 |
152 | MP0009643_abnormal_urine_homeostasis | 0.68962414 |
153 | MP0005000_abnormal_immune_tolerance | 0.68813151 |
154 | MP0001835_abnormal_antigen_presentation | 0.68330811 |
155 | MP0003806_abnormal_nucleotide_metabolis | 0.67869117 |
156 | MP0005535_abnormal_body_temperature | 0.67830650 |
157 | MP0001188_hyperpigmentation | 0.67568638 |
158 | MP0001986_abnormal_taste_sensitivity | 0.67486786 |
159 | MP0008874_decreased_physiological_sensi | 0.67145737 |
160 | MP0001845_abnormal_inflammatory_respons | 0.66962698 |
161 | MP0002877_abnormal_melanocyte_morpholog | 0.66538173 |
162 | MP0001177_atelectasis | 0.66030331 |
163 | MP0008469_abnormal_protein_level | 0.63281562 |
164 | MP0001790_abnormal_immune_system | 0.62286118 |
165 | MP0005387_immune_system_phenotype | 0.62286118 |
166 | MP0002102_abnormal_ear_morphology | 0.62052281 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoglycemic seizures (HP:0002173) | 5.07968296 |
2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.98608735 |
3 | Hypoglycemic coma (HP:0001325) | 4.56640315 |
4 | Ketoacidosis (HP:0001993) | 4.53489077 |
5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.46665125 |
6 | Increased cerebral lipofuscin (HP:0011813) | 4.37785915 |
7 | Hyperglycemia (HP:0003074) | 4.23725327 |
8 | Focal motor seizures (HP:0011153) | 4.00506681 |
9 | Large for gestational age (HP:0001520) | 4.00039922 |
10 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.99918590 |
11 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.99918590 |
12 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.76194065 |
13 | Hypoplasia of the fovea (HP:0007750) | 3.76194065 |
14 | Symptomatic seizures (HP:0011145) | 3.52750887 |
15 | Congenital stationary night blindness (HP:0007642) | 3.47680743 |
16 | Enlarged penis (HP:0000040) | 3.43309616 |
17 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.42776050 |
18 | Hyperventilation (HP:0002883) | 3.33839880 |
19 | Atonic seizures (HP:0010819) | 3.32159233 |
20 | Late onset (HP:0003584) | 3.29343856 |
21 | Absence seizures (HP:0002121) | 3.28575558 |
22 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.27773923 |
23 | Increased CSF protein (HP:0002922) | 3.26790575 |
24 | Vacuolated lymphocytes (HP:0001922) | 3.23615268 |
25 | Progressive neurologic deterioration (HP:0002344) | 3.17952641 |
26 | Polyphagia (HP:0002591) | 3.17872468 |
27 | Hematochezia (HP:0002573) | 3.14484090 |
28 | Ketosis (HP:0001946) | 3.06040375 |
29 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.05370430 |
30 | Generalized tonic-clonic seizures (HP:0002069) | 3.03342589 |
31 | Neurofibrillary tangles (HP:0002185) | 3.03049340 |
32 | Conjunctival hamartoma (HP:0100780) | 3.02819391 |
33 | Ocular albinism (HP:0001107) | 3.00595888 |
34 | Progressive inability to walk (HP:0002505) | 2.95043248 |
35 | Limb dystonia (HP:0002451) | 2.94981959 |
36 | Abnormality of the fovea (HP:0000493) | 2.94460016 |
37 | Dialeptic seizures (HP:0011146) | 2.94431703 |
38 | Hypothermia (HP:0002045) | 2.92130094 |
39 | Albinism (HP:0001022) | 2.89711707 |
40 | Agitation (HP:0000713) | 2.89553277 |
41 | Neuroendocrine neoplasm (HP:0100634) | 2.88461048 |
42 | Double outlet right ventricle (HP:0001719) | 2.87379555 |
43 | Congenital malformation of the right heart (HP:0011723) | 2.87379555 |
44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.85536862 |
45 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.83299309 |
46 | Iris hypopigmentation (HP:0007730) | 2.79620437 |
47 | Congenital sensorineural hearing impairment (HP:0008527) | 2.78947364 |
48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.77189442 |
49 | Blue irides (HP:0000635) | 2.74645507 |
50 | Patchy hypopigmentation of hair (HP:0011365) | 2.74079645 |
51 | Myokymia (HP:0002411) | 2.69884019 |
52 | Clumsiness (HP:0002312) | 2.69237127 |
53 | Hypomagnesemia (HP:0002917) | 2.69132714 |
54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.68161187 |
55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.68161187 |
56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.68161187 |
57 | Intestinal atresia (HP:0011100) | 2.68134552 |
58 | Abnormal hair whorl (HP:0010721) | 2.64856242 |
59 | White forelock (HP:0002211) | 2.64267110 |
60 | Episodic fever (HP:0001954) | 2.64158762 |
61 | Dysostosis multiplex (HP:0000943) | 2.61822387 |
62 | Esophageal neoplasm (HP:0100751) | 2.58654599 |
63 | Neoplasm of head and neck (HP:0012288) | 2.58654599 |
64 | Testicular neoplasm (HP:0010788) | 2.58374834 |
65 | Focal seizures (HP:0007359) | 2.56941053 |
66 | Hamartoma of the eye (HP:0010568) | 2.55728645 |
67 | Increased corneal curvature (HP:0100692) | 2.55718708 |
68 | Keratoconus (HP:0000563) | 2.55718708 |
69 | Generalized hypopigmentation (HP:0007513) | 2.52376955 |
70 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.51853712 |
71 | Postural tremor (HP:0002174) | 2.48512225 |
72 | Abnormality of vitamin B metabolism (HP:0004340) | 2.48483397 |
73 | Pheochromocytoma (HP:0002666) | 2.44615096 |
74 | Nuclear cataract (HP:0100018) | 2.40381168 |
75 | Muscle fibrillation (HP:0010546) | 2.39827032 |
76 | Hyperthyroidism (HP:0000836) | 2.38752599 |
77 | Decreased central vision (HP:0007663) | 2.35031615 |
78 | Hemiparesis (HP:0001269) | 2.33358272 |
79 | Ankle clonus (HP:0011448) | 2.32006185 |
80 | Febrile seizures (HP:0002373) | 2.31893119 |
81 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.30905149 |
82 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.30905149 |
83 | Epileptic encephalopathy (HP:0200134) | 2.30879450 |
84 | Tongue fasciculations (HP:0001308) | 2.30721779 |
85 | Mutism (HP:0002300) | 2.28505172 |
86 | Abolished electroretinogram (ERG) (HP:0000550) | 2.27684668 |
87 | Cerebral inclusion bodies (HP:0100314) | 2.26155837 |
88 | Neuronal loss in central nervous system (HP:0002529) | 2.24876780 |
89 | Supranuclear gaze palsy (HP:0000605) | 2.21246308 |
90 | Poor suck (HP:0002033) | 2.21099270 |
91 | EEG with generalized epileptiform discharges (HP:0011198) | 2.20814509 |
92 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.18868727 |
93 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.18843185 |
94 | Medial flaring of the eyebrow (HP:0010747) | 2.18665299 |
95 | Systemic lupus erythematosus (HP:0002725) | 2.18444538 |
96 | Synostosis involving the elbow (HP:0003938) | 2.18376326 |
97 | Humeroradial synostosis (HP:0003041) | 2.18376326 |
98 | Loss of speech (HP:0002371) | 2.17676918 |
99 | Aqueductal stenosis (HP:0002410) | 2.15667184 |
100 | Acute necrotizing encephalopathy (HP:0006965) | 2.15405341 |
101 | Gait imbalance (HP:0002141) | 2.15277444 |
102 | Epileptiform EEG discharges (HP:0011182) | 2.13198263 |
103 | Abnormality of macular pigmentation (HP:0008002) | 2.10310997 |
104 | Prominent metopic ridge (HP:0005487) | 2.09889716 |
105 | Inability to walk (HP:0002540) | 2.09199819 |
106 | Failure to thrive in infancy (HP:0001531) | 2.08931675 |
107 | Hypsarrhythmia (HP:0002521) | 2.08575673 |
108 | Cutaneous melanoma (HP:0012056) | 2.08496848 |
109 | Generalized myoclonic seizures (HP:0002123) | 2.08477578 |
110 | Diplopia (HP:0000651) | 2.07912986 |
111 | Abnormality of binocular vision (HP:0011514) | 2.07912986 |
112 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.07691085 |
113 | Methylmalonic acidemia (HP:0002912) | 2.06867241 |
114 | Diminished movement (HP:0002374) | 2.06835419 |
115 | Neoplasm of the adrenal cortex (HP:0100641) | 2.06789405 |
116 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.06446748 |
117 | Abnormality of macrophages (HP:0004311) | 2.04325306 |
118 | Gonadal dysgenesis (HP:0000133) | 2.03808202 |
119 | Recurrent abscess formation (HP:0002722) | 2.03171597 |
120 | Eczematoid dermatitis (HP:0000976) | 2.02762710 |
121 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.02381313 |
122 | Vascular calcification (HP:0004934) | 2.02014827 |
123 | Congenital primary aphakia (HP:0007707) | 2.01576040 |
124 | Oligomenorrhea (HP:0000876) | 2.01203698 |
125 | Hyperphosphatemia (HP:0002905) | 2.00816997 |
126 | Recurrent bacterial skin infections (HP:0005406) | 1.98839157 |
127 | Heterochromia iridis (HP:0001100) | 1.98813624 |
128 | Abnormal pupillary function (HP:0007686) | 1.98335827 |
129 | Akinesia (HP:0002304) | 1.98150096 |
130 | Abnormality of vitamin metabolism (HP:0100508) | 1.97833786 |
131 | Stomatitis (HP:0010280) | 1.97501147 |
132 | Cardiomegaly (HP:0001640) | 1.97393172 |
133 | Abnormality of magnesium homeostasis (HP:0004921) | 1.96994619 |
134 | Hypokinesia (HP:0002375) | 1.96912539 |
135 | Sensory axonal neuropathy (HP:0003390) | 1.96699390 |
136 | Muscular hypotonia of the trunk (HP:0008936) | 1.96143745 |
137 | Hypoventilation (HP:0002791) | 1.95479631 |
138 | Myoclonus (HP:0001336) | 1.95067093 |
139 | Orthostatic hypotension (HP:0001278) | 1.94877761 |
140 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93338366 |
141 | Mucopolysacchariduria (HP:0008155) | 1.93338366 |
142 | Progressive cerebellar ataxia (HP:0002073) | 1.92225932 |
143 | Autoamputation (HP:0001218) | 1.90486790 |
144 | Increased IgM level (HP:0003496) | 1.90424137 |
145 | Visual hallucinations (HP:0002367) | 1.89712479 |
146 | Absent speech (HP:0001344) | 1.89343713 |
147 | Widely spaced teeth (HP:0000687) | 1.89027386 |
148 | Abnormal gallbladder physiology (HP:0012438) | 1.88468206 |
149 | Cholecystitis (HP:0001082) | 1.88468206 |
150 | Retinal atrophy (HP:0001105) | 1.88013332 |
151 | Hypoalbuminemia (HP:0003073) | 1.87111913 |
152 | Abnormal albumin level (HP:0012116) | 1.87111913 |
153 | Abnormal eating behavior (HP:0100738) | 1.86687344 |
154 | Macroorchidism (HP:0000053) | 1.86591973 |
155 | Truncal ataxia (HP:0002078) | 1.86180791 |
156 | Central scotoma (HP:0000603) | 1.85115525 |
157 | Petechiae (HP:0000967) | 1.84050189 |
158 | Progressive macrocephaly (HP:0004481) | 1.83516684 |
159 | Methylmalonic aciduria (HP:0012120) | 1.83052000 |
160 | Unilateral renal agenesis (HP:0000122) | 1.82727453 |
161 | Septo-optic dysplasia (HP:0100842) | 1.82319477 |
162 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82260903 |
163 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82260903 |
164 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82260903 |
165 | Anxiety (HP:0000739) | 1.81526900 |
166 | Specific learning disability (HP:0001328) | 1.79468175 |
167 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79226954 |
168 | Abnormality of the corticospinal tract (HP:0002492) | 1.78969427 |
169 | Abnormal drinking behavior (HP:0030082) | 1.77834502 |
170 | Polydipsia (HP:0001959) | 1.77834502 |
171 | Abnormal pancreas size (HP:0012094) | 1.77380495 |
172 | Optic disc pallor (HP:0000543) | 1.77338114 |
173 | Parakeratosis (HP:0001036) | 1.76330528 |
174 | Increased circulating renin level (HP:0000848) | 1.75866870 |
175 | Abnormality of the metopic suture (HP:0005556) | 1.75249407 |
176 | Zonular cataract (HP:0010920) | 1.71229947 |
177 | Intention tremor (HP:0002080) | 1.69983164 |
178 | Cardiovascular calcification (HP:0011915) | 1.64835600 |
179 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.63128639 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 8.24699942 |
2 | CASK | 6.25189236 |
3 | FGFR2 | 3.82427005 |
4 | MAP3K12 | 3.27067236 |
5 | PBK | 2.64451182 |
6 | NTRK3 | 2.49832604 |
7 | FGFR3 | 2.45334142 |
8 | MAP3K4 | 2.32649807 |
9 | MAP3K2 | 2.29154079 |
10 | MAP2K6 | 2.16723545 |
11 | MAP2K7 | 2.15085646 |
12 | ERBB4 | 2.09721138 |
13 | MAP4K2 | 2.08749560 |
14 | NLK | 2.07908426 |
15 | PLK2 | 1.84432524 |
16 | ACVR1B | 1.78981047 |
17 | GRK7 | 1.76955537 |
18 | TAOK1 | 1.75893628 |
19 | LIMK1 | 1.67467543 |
20 | AKT3 | 1.59127752 |
21 | TRPM7 | 1.59114109 |
22 | IRAK2 | 1.58821476 |
23 | ADRBK2 | 1.55316546 |
24 | OXSR1 | 1.53974937 |
25 | MARK1 | 1.47208008 |
26 | MYLK | 1.46656236 |
27 | FER | 1.46142454 |
28 | YES1 | 1.44844318 |
29 | PKN1 | 1.39156656 |
30 | BCR | 1.36235170 |
31 | GRK5 | 1.36178268 |
32 | PRPF4B | 1.35117547 |
33 | NTRK2 | 1.33674589 |
34 | STK3 | 1.32468631 |
35 | PAK6 | 1.30863853 |
36 | MAP3K14 | 1.28460977 |
37 | STK39 | 1.27876211 |
38 | MAP3K3 | 1.26337601 |
39 | PASK | 1.23850013 |
40 | FGR | 1.18736570 |
41 | HIPK2 | 1.18384495 |
42 | MAP3K1 | 1.18219141 |
43 | ARAF | 1.16733623 |
44 | ERBB3 | 1.15768499 |
45 | MAPKAPK5 | 1.12828069 |
46 | TBK1 | 1.12299131 |
47 | MAP2K4 | 1.11512225 |
48 | CAMK2A | 1.10133006 |
49 | PHKG1 | 1.09752799 |
50 | PHKG2 | 1.09752799 |
51 | NTRK1 | 1.04477041 |
52 | SGK223 | 1.04161586 |
53 | SGK494 | 1.04161586 |
54 | FES | 1.02829078 |
55 | PRKCE | 1.01406887 |
56 | MINK1 | 0.97027659 |
57 | CSNK1G3 | 0.95620552 |
58 | STK24 | 0.95362468 |
59 | DAPK2 | 0.93725842 |
60 | PDK2 | 0.92815581 |
61 | BMPR1B | 0.89214171 |
62 | CDK5 | 0.87854140 |
63 | TXK | 0.86781166 |
64 | MAP2K3 | 0.85433533 |
65 | PRKCG | 0.85335402 |
66 | IRAK1 | 0.85310787 |
67 | BLK | 0.85038605 |
68 | PAK3 | 0.84252358 |
69 | CSNK1G2 | 0.84102897 |
70 | LMTK2 | 0.83916945 |
71 | STK4 | 0.82060468 |
72 | CAMK2G | 0.81927549 |
73 | TESK1 | 0.81868066 |
74 | EIF2AK3 | 0.81840153 |
75 | EPHA3 | 0.80645346 |
76 | MAP3K13 | 0.78371538 |
77 | TSSK6 | 0.77976030 |
78 | CAMK2D | 0.77539437 |
79 | PINK1 | 0.77186367 |
80 | CDK19 | 0.76589136 |
81 | PRKD2 | 0.76282923 |
82 | WNK3 | 0.76038174 |
83 | BMPR2 | 0.75256288 |
84 | STK11 | 0.75224361 |
85 | TNK2 | 0.74719066 |
86 | GRK6 | 0.74355395 |
87 | TYRO3 | 0.74166617 |
88 | IRAK4 | 0.72779459 |
89 | CSNK1A1L | 0.72630407 |
90 | GRK1 | 0.71639629 |
91 | ERN1 | 0.71501786 |
92 | IKBKE | 0.70410404 |
93 | PNCK | 0.70052809 |
94 | PRKAA2 | 0.69136845 |
95 | RIPK4 | 0.67974996 |
96 | ADRBK1 | 0.65338678 |
97 | SGK3 | 0.65142740 |
98 | PTK2B | 0.64729619 |
99 | PDK1 | 0.63750123 |
100 | CAMK2B | 0.63368411 |
101 | TYK2 | 0.62905680 |
102 | ITK | 0.62722305 |
103 | MAP3K9 | 0.62599267 |
104 | TNIK | 0.62174710 |
105 | INSRR | 0.61643921 |
106 | MOS | 0.61251653 |
107 | PRKCQ | 0.60627257 |
108 | DAPK3 | 0.58543326 |
109 | PRKCH | 0.58451526 |
110 | ROCK2 | 0.58126012 |
111 | PDGFRA | 0.57598535 |
112 | GSK3A | 0.57369524 |
113 | PRKG2 | 0.57153801 |
114 | CSK | 0.57011808 |
115 | IRAK3 | 0.56517129 |
116 | EPHB1 | 0.55290660 |
117 | DDR2 | 0.55057658 |
118 | TESK2 | 0.54965800 |
119 | CDK14 | 0.53605911 |
120 | STK38 | 0.52616579 |
121 | PDPK1 | 0.52518342 |
122 | TAOK3 | 0.52398743 |
123 | MST4 | 0.51992834 |
124 | FYN | 0.51573678 |
125 | CAMKK2 | 0.50613880 |
126 | CSNK1G1 | 0.50382148 |
127 | DAPK1 | 0.50321779 |
128 | SGK2 | 0.50200823 |
129 | ZAP70 | 0.49253709 |
130 | LYN | 0.49072896 |
131 | SIK3 | 0.48988237 |
132 | JAK1 | 0.48800821 |
133 | KIT | 0.48372460 |
134 | WNK4 | 0.48048623 |
135 | CDK3 | 0.47965738 |
136 | STK38L | 0.47732878 |
137 | IKBKB | 0.46986838 |
138 | RET | 0.45801014 |
139 | UHMK1 | 0.45777656 |
140 | HCK | 0.45496580 |
141 | MUSK | 0.45488652 |
142 | ROCK1 | 0.44902860 |
143 | IGF1R | 0.44530688 |
144 | LCK | 0.44528321 |
145 | MARK3 | 0.40464992 |
146 | MAPK7 | 0.36134199 |
147 | MAP4K1 | 0.36083333 |
148 | STK10 | 0.33124431 |
149 | PRKG1 | 0.31950002 |
150 | JAK2 | 0.31908929 |
151 | PRKCZ | 0.31725181 |
152 | EIF2AK1 | 0.30721124 |
153 | PRKAA1 | 0.30712814 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.23645387 |
2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.73588185 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.20822762 |
4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.83335930 |
5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.57558284 |
6 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.42174913 |
7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.37727669 |
8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.34389432 |
9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.33126078 |
10 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.20501809 |
11 | Phagosome_Homo sapiens_hsa04145 | 2.15174389 |
12 | Lysosome_Homo sapiens_hsa04142 | 2.10351632 |
13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.95040088 |
14 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.93100387 |
15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.88159218 |
16 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.87396630 |
17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.83691048 |
18 | Morphine addiction_Homo sapiens_hsa05032 | 1.82684013 |
19 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.74169800 |
20 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.70406226 |
21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.56434835 |
22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.45174971 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43602089 |
24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43237682 |
25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40955543 |
26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40201601 |
27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39318539 |
28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34348704 |
29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.31772223 |
30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31418809 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30690203 |
32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.29673801 |
33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.24228279 |
34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23281494 |
35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.22544056 |
36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20341050 |
37 | Phototransduction_Homo sapiens_hsa04744 | 1.13991406 |
38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11898655 |
39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.05836058 |
40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03485498 |
41 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.02709787 |
42 | Circadian entrainment_Homo sapiens_hsa04713 | 1.00630728 |
43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99533767 |
44 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.98941072 |
45 | Olfactory transduction_Homo sapiens_hsa04740 | 0.98762350 |
46 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97864102 |
47 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96339617 |
48 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.95470079 |
49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.94269140 |
50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94198713 |
51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93930369 |
52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93370489 |
53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92073421 |
54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89508813 |
55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88470652 |
56 | Malaria_Homo sapiens_hsa05144 | 0.87206342 |
57 | Prion diseases_Homo sapiens_hsa05020 | 0.85872694 |
58 | Renin secretion_Homo sapiens_hsa04924 | 0.84820273 |
59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82965510 |
60 | Cocaine addiction_Homo sapiens_hsa05030 | 0.82831670 |
61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82357128 |
62 | Legionellosis_Homo sapiens_hsa05134 | 0.81603185 |
63 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79905589 |
64 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.79390690 |
65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.77979864 |
66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77609186 |
67 | Long-term depression_Homo sapiens_hsa04730 | 0.75278165 |
68 | Salivary secretion_Homo sapiens_hsa04970 | 0.74776720 |
69 | ABC transporters_Homo sapiens_hsa02010 | 0.74099880 |
70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74052610 |
71 | Taste transduction_Homo sapiens_hsa04742 | 0.71736222 |
72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71430891 |
73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.71015954 |
74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.70506738 |
75 | Allograft rejection_Homo sapiens_hsa05330 | 0.70096286 |
76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.69697799 |
77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68308082 |
78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66641170 |
79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65869809 |
80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65767163 |
81 | Insulin resistance_Homo sapiens_hsa04931 | 0.62699765 |
82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62421957 |
83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62340843 |
84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61645585 |
85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61593151 |
86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61458740 |
87 | Peroxisome_Homo sapiens_hsa04146 | 0.60719876 |
88 | Tuberculosis_Homo sapiens_hsa05152 | 0.59104163 |
89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57877737 |
90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56829639 |
91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56037298 |
92 | Axon guidance_Homo sapiens_hsa04360 | 0.55538180 |
93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55318246 |
94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54978447 |
95 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.54598113 |
96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54270277 |
97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53503736 |
98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53071363 |
99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51816919 |
100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51610695 |
101 | Insulin secretion_Homo sapiens_hsa04911 | 0.50549451 |
102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48316843 |
103 | Gap junction_Homo sapiens_hsa04540 | 0.47797113 |
104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45850724 |
105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45769946 |
106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45086945 |
107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44088810 |
108 | Salmonella infection_Homo sapiens_hsa05132 | 0.44003502 |
109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43670938 |
110 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43647046 |
111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43319090 |
112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43212106 |
113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43034254 |
114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42948131 |
115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42705057 |
116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42286820 |
117 | Asthma_Homo sapiens_hsa05310 | 0.40973440 |
118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40396923 |
119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40071395 |
120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39791165 |
121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39600012 |
122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39344368 |
123 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37601163 |
124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36761796 |
125 | Protein export_Homo sapiens_hsa03060 | 0.36500080 |
126 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35719099 |
127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35669905 |
128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35457076 |
129 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35357298 |
130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34505062 |
131 | Pertussis_Homo sapiens_hsa05133 | 0.33187909 |
132 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.32937814 |
133 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32930247 |
134 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.32656209 |
135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32602923 |
136 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32506811 |
137 | Mineral absorption_Homo sapiens_hsa04978 | 0.32483419 |
138 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32423324 |
139 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31470888 |
140 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31137365 |
141 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.30528392 |
142 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.30463635 |
143 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30118856 |
144 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.30017624 |
145 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28557240 |
146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27472301 |
147 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27401677 |
148 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.27123419 |
149 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.26271198 |
150 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.25162108 |
151 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25029136 |